HA
Hapvida Participações e Investimentos S.A.
HAPV3.SA · SAO
R$ 8.78 +12.56% (+R$ 0.98)
1M +8.48%
Market Cap R$ 4.17B
P/E Ratio -
Div. Yield -
ROE 0.36%
Bulios Fair Price
R$ 5.93
32.5% downside
Current Price
R$ 8.78
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAPV3.SA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
96 /100
Cheap EV/EBITDA 7.84x
P/S 0.23x
P/B 0.09x
Growth
57 /100
Stable Rev. growth 9.96%
Book val. growth 0.34%
EPS growth N/A
Profitability
15 /100
Weak Gross margin 18.95%
Net margin 0.94%
Op. margin 7.42%
Quality
10 /100
Poor ROIC 3.26%
ROE 0.36%
ROA 0.24%
Debt
45 /100
Moderate Debt/Equity 0.32x
Current ratio 1.83x
Int. coverage 0.65x
Stability
34 /100
Moderate Beta 0.26x
Rev. volatility 7.16%
EPS volatility 889.55%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAPV3.SA
Online
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Luccas Adib
Employees
66,000
Headquarters
Fortaleza
Upcoming events
11 NOV
Earnings
Upcoming earnings report